Tri Locum Partners LP PRAX PRAXIS PRECISION MEDICINES I

Ownership history in Tri Locum Partners LP  ·  7 quarters on record

AI Ownership Summary

Tri Locum Partners LP reported PRAXIS PRECISION MEDICINES I (PRAX) in 7 quarterly 13F filings from 2023 Q4 through 2025 Q3. Peak portfolio weight reached 2.53% in 2023 Q4. The latest visible filing shows PRAX at 0.93% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this PRAX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Tri Locum Partners LP's position in PRAXIS PRECISION MEDICINES I, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q3

PRAX was reported at 0.93% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
2.53% in 2023 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q3

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Tri Locum Partners LP held PRAX — position size vs. price
% of Fund (quarterly)    PRAX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 7 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q3 REDUCED 61.1% +474.7% 75,986 -119,446 -61.1% 0.93% $4.0M 2025-11-14 $186.42
2025 Q2 ADDED 195,432 +111,773 +133.6% 2.49% $8.2M 2025-08-14 $47.70
2025 Q1 ADDED 83,659 +46,390 +124.5% 1.63% $3.2M 2025-05-14 $37.10
2024 Q4 REDUCED 50.5% -50.8% 37,269 -38,050 -50.5% 0.59% $2.9M 2025-02-14 $90.77
2024 Q2 REDUCED 29.3% +39.1% 75,319 -31,175 -29.3% 0.79% $3.1M 2024-08-14 $51.26
2024 Q1 REDUCED 57.2% -32.5% 106,494 -142,267 -57.2% 2.25% $6.5M 2024-05-15 $44.00
2023 Q4 INITIATED 248,761 2.53% $5.5M 2024-02-14 $42.29

FAQ About Tri Locum Partners LP and PRAX

These are the practical questions this page is built to answer before you even open the full history table.

How long has Tri Locum Partners LP reported owning PRAX?

Tri Locum Partners LP reported PRAX across 7 quarterly 13F filings, from 2023 Q4 through 2025 Q3.

What was the largest reported PRAX position in Tri Locum Partners LP's portfolio?

The largest reported portfolio weight for PRAX was 2.53% in 2023 Q4.

What is the latest reported PRAX position on this page?

The most recent filing on this page is 2025 Q3, when Tri Locum Partners LP reported 75,986 shares, equal to 0.93% of portfolio, with an estimated market value of $4.0M.

What does the chart on this PRAX ownership page compare?

The chart compares Tri Locum Partners LP's quarterly PRAX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Tri Locum Partners LP time their PRAX position?

Based on 13F filing dates vs. subsequent PRAX price moves, Tri Locum Partners LP correctly timed 4 out of 6 reported position changes (67%). The annualised alpha on PRAX relative to SPY over the holding period was +94.5%.

← Back to Tri Locum Partners LP Holdings